Bufotalin targets COL1A1 to suppress non-small cell lung cancer growth and remodel the tumor microenvironment via dual inhibition of PI3K/AKT/mTOR and MAPK pathways
Author:
Yuxiu Zhang,Panpan Lei,Jinna Liang,Sifan Xie,Xiaoyu Ma,Weina Ma
Publication:
European Journal of Pharmacology
© 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.